Prilenia Appoints Dr. Elisabeth Leiderman as Chief Financial Officer
Autolus Therapeutics plc - American Depositary Shares (AUTL)
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am
Check Earnings Report
US:NASDAQ Investor Relations:
autolus.com/investor-relations
Company Research
Source: Business Wire
NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and Amyotrophic Lateral Sclerosis (ALS), today announced the appointment of Elisabeth (Lis) Leiderman, MD, MBA, as Chief Financial Officer.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428964437/en/Elisabeth (Lis) Leiderman, MD, MBA, Prilenia's Chief Financial Officer“Lis is a physician and neuroscientist by training, bringing a rare and exciting combination of scientific training, financial expertise, deal-making and strategic vision,” said Dr. Michael R. Hayden, Chief Executive Officer of Prilenia Therapeutics. “She will play a key role as we execute on our mission to deliver pridopidine to people with HD, ALS and potentially other neurodegenerative diseases. I am thr
Show less
Read more
Impact Snapshot
Event Time:
AUTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUTL alerts
High impacting Autolus Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AUTL
News
- Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost ReductionGlobeNewswire
- Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial RecognitionGlobeNewswire
- Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Autolus Therapeutics (AUTL) was upgraded by Jefferies Financial Group Inc. to "strong-buy".MarketBeat
- How The Autolus Therapeutics (AUTL) Narrative Is Shifting With Recalibrated Targets And Fair Value [Yahoo! Finance]Yahoo! Finance
AUTL
Earnings
- 3/27/26 - Miss
AUTL
Sec Filings
- 4/29/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/15/26 - Form DEL
- AUTL's page on the SEC website